Unity has acquired AI game developer tools startup Artomatix. The Dublin startup builds developer tools that allow game studios to more easily create deep learning-enhanced textures that scale more ...
Unity Technologies, the highly valued startup behind one of the most popular game development tools, lost its CFO Mike Foley last week, Business Insider (paywalled) reported. A company spokesperson ...
A pair of highly-funded gaming unicorns are publicly skirmishing and the deal could have major repercussions for game developers. Today, UK-based cloud gaming startup Improbable, announced that Unity, ...
Unity Personal and Unity Plus subscribers will pay $0.20 per install after reaching $200,000 in revenue from the past 12 months and 200,000 lifetime installs. Meanwhile, after hitting $1 million in ...
Unity Technologies, the company behind the Unity game development toolkit, was able to raise $181 million in a Series C funding round that values the company at about $1.5 billion. The funding round ...
A biotech startup that wants to clear cells related to aging from our bodies just got $116 million to test out how its technology might work in people. Unity Biotechnology, which came out of stealth ...
Metadium, a South Korean blockchain identity startup, is releasing its Software Development Kit (SDK) on leading game engine Unity’s Asset Store, according to a press release published today, March 15 ...
Unity Software Inc will look to raise up to $1.05 billion in its initial public offering, it said on Wednesday, giving the Silicon Valley-based software startup a valuation of about $11.06 billion.
Buzzy British game tech startup Improbable says its cloud gaming platform has been blocked by Unity. Improbably says that Unity, which claims to be the most popular game engine, changed its terms of ...
Unity Biotechnology, a startup based at Novato’s Buck Institute for Research on Aging, is teaming with a China-based biopharmaceutical company on treatments for age-accentuated ailments. Unity has ...
In biotechnology, sometimes a CEO’s personal pain motivates scientific gain. Osteoarthritic pain in Nathaniel “Ned” David’s toes serves as a personal driver for the Unity Biotechnology First Company ...